Healthcare AI Tools: 2026 Predictions With Real Operational Moves
2025 proved something: AI can handle the unglamorous work that slows care. 2026 will test who can plug it into real workflows, safely, and at clinical speed.
Below are the most useful predictions from healthcare operators, clinicians, and builders - plus the actions you can take now to get value this year.
Ambient AI moves beyond notes and into the pharmacy loop
Ambient documentation is already cutting burnout. One study showed a 21% reduction in under three months. Colin Banas, Chief Medical Officer at DrFirst, expects the next step: AI linking prescribers, pharmacies, and payers to end phone tag and fax chases so scripts arrive ready to fill and therapy starts sooner.
From pilots to plumbing: AI must fit the workflow
Edmund Jackson, Co-Founder and CEO at UnityAI, points out that last-mile work like outreach and scheduling is now automatable. In 2026, tools that fail to integrate will be dropped. Craig Limoli, CEO at Wellsheet, sees AI agents handling background tasks - summaries, reminders, insights - so clinicians can focus on patients.
Trust is the line in the sand. David Minkin, President and GM, epocrates at athenahealth, says winners will be transparent, fast, and accurate. Greg Samios, CEO at Wolters Kluwer Health, stresses expert-in-the-loop oversight, citations, and guardrails to keep care safe while improving efficiency.
AI prescribing begins - narrowly and with oversight
Adam Oskowitz, Vascular Surgeon at UCSF and Co-Founder of Doctronic, expects at least three U.S. states to authorize AI to prescribe within narrow formularies and strict controls. He also anticipates at-home hardware plus AI delivering pieces of primary care - faster triage, better access, less pressure on clinics.
Targeted interventions replace blanket programs
Matt Hanauer, Ph.D, Senior Director, Data Science at MedeAnalytics, predicts a shift from broad point solutions to AI-guided targeting. Organizations will deploy interventions only where historical and projected ROI indicates meaningful outcomes, improving both clinical impact and financial performance.
Medicaid adopts AI with shared guardrails
Daniel Hallenbeck, VP of Strategy at Acentra Health, expects states to embed AI in lower-risk workflows: case research, document summaries, 24/7 secure chat, and system modernization. Adoption will lean on frameworks like the NIST AI Risk Management Framework and efforts such as SAMA to standardize risk tiers and oversight.
Clinical trials: AI moves into operations and finance
Zahiah (Zee Zee) Gueddar, Senior Director at IQVIA Clinical Trial Financial Suite, anticipates sponsors bringing trial finance functions in-house, pairing advanced AI with domain expertise for speed, control, and stronger site relationships. Ece Kalvaci, Software Engineer at Lindus Health, expects a push for transparency, auditability, and governance as agentic AI coordinates across clinical, data, and ops teams.
Oncology: digital-only biomarkers enter decision pathways
Tathagata Dasgupta, Founder and President at 4D Path, sees physics-informed AI extracting insights from tumor images that predict behavior and treatment response. Digital-only biomarkers will appear as pre-specified endpoints and begin to guide therapy choices, even uncovering resistance mechanisms from routine H&E slides.
Diagnostics: generalist AI assistants get competitive
Amy Cheetham, Partner at Costanoa Ventures, expects a generalist diagnostic assistant to match or beat specialists across 20+ conditions, using imaging, labs, history, and notes. Providers already report high usage rates for ambient tools, and AI that sits on top of legacy EHRs reduces manual effort without full system replacement.
Workforce: AI becomes a staffing strategy
Michelle Hilburn, MSN, RN, CPHQ, CPPS, AVP at Vastian, frames AI as essential to offset retirements, burnout, and nurse vacancies. Expect reclaimed clinical time and less friction from documentation and discharge bottlenecks. Angel Mena, Chief Medical Officer at symplr, calls for training the next wave of digitally enabled clinicians, noting clinicians already spend about 88 minutes a day on admin tasks.
MedTech: value proof on demand
Michael Monovoukas, Co-Founder and CEO at AcuityMD, sees AI producing instant analytics to quantify clinical and financial impact. Manufacturers that can show outcomes and cost alignment on demand will move faster with provider and CFO buyers.
Appropriateness, outcomes, and real-world data get teeth
Kumar Dharmarajan, Co-Founder and Chief Medical Officer at World Class Health, expects AI-driven analytics to guide which procedures happen, where, and with what expected results - with high-cost specialties leading. With CMS pushing transparency and prior authorization reform, EHR-integrated appropriateness tools and routine patient-reported outcomes will become core infrastructure. See CMS's work on prior authorization reforms here.
What to do next
- Pick two workflows to automate by mid-year: prior authorization pre-checks and visit documentation summarization are proven starting points.
- Require EHR integration that doesn't add clicks. Test in live clinics, not just sandboxes.
- Adopt a risk framework. Start with the NIST AI RMF. Define risk tiers, audit trails, human-in-the-loop points, and rollback plans.
- Set clinical speed standards: response times under 2 seconds for in-visit support; zero added steps for clinicians.
- Demand transparency: source citations, change logs, and clear failure modes. No black boxes in clinical workflows.
- Track five metrics weekly: documentation time per encounter, clinician burnout sentiment, time-to-therapy for new scripts, prior auth days-in-queue, and intervention ROI by member segment.
- Stand up AI agents for background tasks: inbox triage, chart summaries, referral coordination, and outreach scheduling - with human review where needed.
- For Medicaid teams: start with document summarization and secure member chat with strict answer limits and escalation rules.
- For trials: pilot digital biomarkers as exploratory endpoints; build auditability into every agent task from day one.
- For MedTech: bring outcome and cost calculators to every sales meeting, with de-identified, replicable data.
- Invest in clinician enablement: short sessions on safe AI use, verification habits, and workflow tips. If you need structured training by role, explore AI courses by job.
- Refresh PHI safeguards: access controls, de-identification for model training, vendor BAAs, and data retention policies.
Signals to watch in 2026
- States approving tightly scoped AI prescribing with clear oversight.
- Health systems moving from point solutions to platform-level agents embedded across service lines.
- Digital-only biomarkers cited in trial protocols and tumor boards.
- Payers and employers steering volume to Centers of Excellence using real-world outcomes, not reputation.
Bottom line: this is the year AI gets judged on fit, trust, and outcomes. Keep it simple, measure everything, and keep clinicians in control.
What are you seeing inside your organization? Share your experiences and roadblocks - the details help the whole industry get smarter.
Your membership also unlocks:
